<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "http://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" dtd-version="1.1" specific-use="sps-1.9" article-type="editorial" xml:lang="pt">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Arq Bras Cardiol</journal-id>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id specific-use="scielo-v3" pub-id-type="publisher-id">4ZpnSS38b3yk7nDJmtRwgnj</article-id>
      <article-id specific-use="scielo-v2" pub-id-type="publisher-id">S0066-782X2021001000279</article-id>
      <article-id pub-id-type="publisher-id">abc.20210509</article-id>
      <article-id pub-id-type="doi">10.36660/abc.20210509</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Minieditorial</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Uso de Estatina Associado ao Treinamento F&#237;sico: Uma Combina&#231;&#227;o Perfeita</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Motta</surname>
            <given-names>Stephanie Bastos da</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="editor">
          <name>
            <surname>Toledes</surname>
            <given-names>Vanessa Caroline</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="editor">
          <contrib-id contrib-id-type="orcid">0000-0002-6327-1428</contrib-id>
          <name>
            <surname>Franzoni</surname>
            <given-names>Leandro</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
          <xref ref-type="corresp" rid="c1"/>
        </contrib>
        <aff id="aff1">
          <label>1</label>
          <institution content-type="orgname">Hospital de Cl&#237;nicas de Porto Alegre</institution>
          <addr-line>
            <named-content content-type="city">Porto Alegre</named-content>
            <named-content content-type="state">RS</named-content>
          </addr-line>
          <country country="BR">Brasil</country>
          <institution content-type="original">Hospital de Cl&#237;nicas de Porto Alegre - Grupo de Vascular e Exerc&#237;cio &#8211; VascuEx, Porto Alegre, RS - Brasil</institution>
        </aff>
        <aff id="aff2">
          <label>2</label>
          <institution content-type="orgname">Faculdade Cenecista Santo &#194;ngelo</institution>
          <addr-line>
            <named-content content-type="city">Santo &#194;ngelo</named-content>
            <named-content content-type="state">RS</named-content>
          </addr-line>
          <country country="BR">Brasil</country>
          <institution content-type="original">Faculdade Cenecista Santo &#194;ngelo - Curso de Fisioterapia, Santo &#194;ngelo, RS - Brasil</institution>
        </aff>
        <aff id="aff3">
          <label>3</label>
          <institution content-type="orgname">Universidade Federal do Rio Grande do Sul - UFRGS</institution>
          <addr-line>
            <named-content content-type="city">Porto Alegre</named-content>
            <named-content content-type="state">RS</named-content>
          </addr-line>
          <country country="BR">Brasil</country>
          <institution content-type="original">Universidade Federal do Rio Grande do Sul &#8211; UFRGS, Porto Alegre, RS - Brasil</institution>
        </aff>
      </contrib-group>
      <author-notes>
        <corresp id="c1"><bold>Correspond&#234;ncia: Leandro Franzoni</bold> &#8226; Universidade Federal do Rio Grande do Sul &#8211; UFRGS - Rua Itabora&#237;, 683. CEP <postal-code>90040-060</postal-code>, Porto Alegre, RS &#8211; Brasil. E-mail: <email>franzoni_77@hotmail.com</email></corresp>
      </author-notes>
      <pub-date publication-format="electronic" date-type="pub">
        <day>06</day>
        <month>09</month>
        <year>2021</year>
      </pub-date>
      <pub-date publication-format="electronic" date-type="collection">
        <month>08</month>
        <year>2021</year>
      </pub-date>
      <volume>117</volume>
      <issue>2</issue>
      <fpage>279</fpage>
      <lpage>280</lpage>
      <permissions>
        <license license-type="open-access" xml:lang="en" xlink:href="https://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License</license-p>
        </license>
      </permissions>
      <kwd-group xml:lang="pt">
        <title>Palavras-chave:</title>
        <kwd>Dislipidemias/preven&#231;&#227;o e controle</kwd>
        <kwd>S&#237;ndrome X Metab&#243;lica</kwd>
        <kwd>Inibidores de Hidroximetilglutaril-CoA Redutases</kwd>
        <kwd>Fatores de Risco</kwd>
        <kwd>Exerc&#237;cio</kwd>
        <kwd>Esportes</kwd>
        <kwd>Nata&#231;&#227;o</kwd>
      </kwd-group>
      <counts>
        <fig-count count="0"/>
        <table-count count="0"/>
        <equation-count count="0"/>
        <ref-count count="11"/>
        <page-count count="2"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <p>A dislipidemia e a s&#237;ndrome metab&#243;lica crescem exponencialmente nos &#250;ltimos anos, inclusive em crian&#231;as, principalmente pela baixa qualidade da alimenta&#231;&#227;o e pelo elevado n&#237;vel de sedentarismo populacional.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref><sup>&#8211;</sup><xref ref-type="bibr" rid="B3"><sup>3</sup></xref> Essas duas doen&#231;as s&#227;o importantes fatores de risco para o desenvolvimento de doen&#231;as cardiovasculares.<xref ref-type="bibr" rid="B4"><sup>4</sup></xref> A redu&#231;&#227;o da lipoprote&#237;na de baixa densidade (LDL), bem como do colesterol total (CT) e da rela&#231;&#227;o CT pela lipoprote&#237;na de alta densidade (HDL &#8211; CT/HDL) s&#227;o as principais formas de preven&#231;&#227;o cardiometab&#243;lica.<xref ref-type="bibr" rid="B5"><sup>5</sup></xref> O uso de estatinas &#233; considerado tratamento padr&#227;o, sendo a medida farmacol&#243;gica mais eficaz para melhorar o perfil lip&#237;dico.<xref ref-type="bibr" rid="B6"><sup>6</sup></xref> No entanto, existem alternativas n&#227;o farmacol&#243;gicas que tamb&#233;m s&#227;o eficazes, sendo uma delas o exerc&#237;cio f&#237;sico.</p>
    <p>Diferentes evid&#234;ncias trazem a import&#226;ncia da ades&#227;o ao treinamento f&#237;sico regular como forma de preven&#231;&#227;o prim&#225;ria ou secund&#225;ria no desenvolvimento ou agravamento de doen&#231;as cardiometab&#243;licas.<xref ref-type="bibr" rid="B7"><sup>7</sup></xref><sup>&#8211;</sup><xref ref-type="bibr" rid="B9"><sup>9</sup></xref> No entanto, ainda n&#227;o h&#225; um consenso sobre o efeito da combina&#231;&#227;o entre o uso de estatinas com o treinamento f&#237;sico, duas poderosas ferramentas que, combinadas, podem promover um impacto ainda maior no perfil lip&#237;dico. Foi o que Costa et al.<xref ref-type="bibr" rid="B10"><sup>10</sup></xref> fizeram nesta edi&#231;&#227;o dos Arquivos Brasileiros de Cardiologia, analisando a influ&#234;ncia do uso de sinvastatina nas adapta&#231;&#245;es lip&#237;dicas decorrentes do treinamento aer&#243;bico e de for&#231;a em meio aqu&#225;tico em mulheres idosas com dislipidemia. Para tal, foram analisadas 69 mulheres idosas (66,13&#177;5,13 anos), sedent&#225;rias, dislipid&#234;micas, tanto n&#227;o usu&#225;rias quanto usu&#225;rias de sinvastatina (20 mg e 40 mg).</p>
    <p>Vamos destacar os principais pontos metodol&#243;gicos do artigo a seguir: trata-se de um ensaio cl&#237;nico randomizado, com 3 grupos (treinamento aer&#243;bico em meio aqu&#225;tico &#8211; WA; treinamento de for&#231;a em meio aqu&#225;tico &#8211; WR; grupo controle &#8211; GC). A interven&#231;&#227;o teve dura&#231;&#227;o de 10 semanas (2 vezes por semana) para todos os grupos. O grupo WA foi composto por 23 mulheres (10 em uso de estatina e 13 sem uso de estatina); o grupo WR foi composto por 23 mulheres (9 em uso de estatina e 14 sem uso de estatina); e o GC foi composto por 23 mulheres (9 sem uso de estatina e 14 sem uso de estatina). Destacamos aqui o primeiro ponto positivo do estudo: randomiza&#231;&#227;o bem executada com n amostral igual em todos os grupos e distribui&#231;&#227;o correta de uso de estatina.</p>
    <p>Em rela&#231;&#227;o ao programa de treinamento f&#237;sico aqu&#225;tico, as participantes dos grupos WA e WR realizaram 2 sess&#245;es de familiariza&#231;&#227;o antes do in&#237;cio do seguimento. Al&#233;m disso, a intensidade de exerc&#237;cio foi aumentada ap&#243;s 5 semanas de interven&#231;&#227;o. As sess&#245;es de exerc&#237;cio tiveram dura&#231;&#227;o de 45 minutos, sendo 8 minutos de aquecimento, 30 minutos de parte principal e 7 minutos de desaquecimento. Para o grupo WA, adotou-se o treinamento intervalado com intensidade entre 90% e 100% da frequ&#234;ncia card&#237;aca correspondente ao limiar anaer&#243;bio (FC<sub>LA</sub>). J&#225; o grupo WR realizou os exerc&#237;cios adotando velocidade m&#225;xima de execu&#231;&#227;o, e tamb&#233;m manteve um tempo fixo de 1 minuto e 20 segundos para cada exerc&#237;cio, enquanto o GC realizou um programa n&#227;o periodizado de exerc&#237;cios de relaxamento em imers&#227;o, com a finalidade de manter a mesma quantidade de sess&#245;es semanais dos outros grupos. O segundo m&#233;rito do trabalho foi controlar a intensidade de exerc&#237;cio pela FC<sub>LA</sub>, al&#233;m de periodizar o treinamento f&#237;sico, planejando o incremento da intensidade durante o seguimento.</p>
    <p>A seguir, destacaremos os principais achados do estudo: em resumo, o uso de estatina associado ao treinamento f&#237;sico melhora LDL, CT e CT/HDL. Quanto? Participantes medicadas para LDL: &#8722;5,58 a 25,18 mg.dl<sup>&#8722;1</sup>; CT: &#8722;3,41 a 25,89 mg.dl<sup>&#8722;1</sup>; CT/HDL: &#8722;0,37 a 0,61 mg.dl<sup>&#8722;1</sup>, com p significativo quando comparado &#224;s participantes n&#227;o medicadas, sendo essa redu&#231;&#227;o estatisticamente significativa apenas para o grupo WR. De modo geral, o uso de estatina associado ao treinamento de for&#231;a em meio aqu&#225;tico parece ser a estrat&#233;gia mais eficaz na redu&#231;&#227;o dos par&#226;metros lip&#237;dicos avaliados no presente estudo.</p>
    <p>Sabemos da import&#226;ncia do treinamento f&#237;sico aer&#243;bico, principalmente pela sua prote&#231;&#227;o em rela&#231;&#227;o a diversos fatores de risco cardiovascular. No entanto, diferentes evid&#234;ncias sugerem que o treinamento de for&#231;a &#233; a ferramenta mais eficaz para melhorar o perfil lip&#237;dico, principalmente aumentando o HDL, e consequentemente reduzindo CT/HDL.<xref ref-type="bibr" rid="B11"><sup>11</sup></xref> Durante a pr&#225;tica cl&#237;nica, os especialistas sabem que o treinamento f&#237;sico combinado, ou seja, aer&#243;bico e for&#231;a juntos, na mesma sess&#227;o ou em sess&#245;es diferentes, apresenta benef&#237;cios em diversos par&#226;metros e acaba sendo o mais utilizado no dia a dia profissional, somando os benef&#237;cios tanto do exerc&#237;cio aer&#243;bico quanto do exerc&#237;cio de for&#231;a. O estudo apresenta muitos m&#233;ritos, no entanto podemos sugerir que para os pr&#243;ximos estudos, seja comparado o efeito do treinamento combinado e tamb&#233;m em homens dislipid&#234;micos, inclusive ampliando a faixa et&#225;ria, visto que os resultados do presente estudo servem apenas para mulheres idosas.</p>
  </body>
  <back>
    <fn-group>
      <fn fn-type="other" id="fn1">
        <p>Minieditorial referente ao artigo: Uso de Estatinas Melhora a Prote&#231;&#227;o Cardiometab&#243;lica Promovida pelo Treinamento F&#237;sico em Ambiente Aqu&#225;tico: Um Ensaio Cl&#237;nico Randomizado</p>
      </fn>
    </fn-group>
    <ack>
      <title>Agradecimentos</title>
      <p>&#192; Coordena&#231;&#227;o de Aperfei&#231;oamento de Pessoal de N&#237;vel Superior (CAPES) pela concess&#227;o da bolsa de doutorado e ao Programa de Ci&#234;ncias da Sa&#250;de: Cardiologia e Ci&#234;ncias Cardiovasculares pertencente &#224; Universidade Federal do Rio Grande do Sul pela oportunidade de trabalho.</p>
    </ack>
    <ref-list>
      <title>Refer&#234;ncias</title>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saklayen</surname>
              <given-names>MG</given-names>
            </name>
          </person-group>
          <article-title>The Global Epidemic of the Metabolic Syndrome</article-title>
          <source>Curr Hypertens Rep</source>
          <year>2018</year>
          <volume>20</volume>
          <issue>2</issue>
          <fpage>12</fpage>
          <lpage>12</lpage>
          <pub-id pub-id-type="doi">10.1007/s11906-018-0812-z</pub-id>
        </element-citation>
        <mixed-citation>1. Saklayen MG. The Global Epidemic of the Metabolic Syndrome. Curr Hypertens Rep. 2018;20(2):12. doi: 10.1007/s11906-018-0812-z.</mixed-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gomes</surname>
              <given-names>IL</given-names>
            </name>
            <name>
              <surname>Zago</surname>
              <given-names>VHS</given-names>
            </name>
            <name>
              <surname>Faria</surname>
              <given-names>EC</given-names>
            </name>
          </person-group>
          <article-title>Avalia&#231;&#227;o de Perfis Lip&#237;dicos Infanto-Juvenis Solicitados nas Unidades B&#225;sicas de Sa&#250;de em Campinas/SP, Brasil: Um Estudo Laboratorial Transversal</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2020</year>
          <volume>114</volume>
          <issue>1</issue>
          <fpage>47</fpage>
          <lpage>56</lpage>
        </element-citation>
        <mixed-citation>2. Gomes IL, Zago VHS, Faria EC. Avalia&#231;&#227;o de Perfis Lip&#237;dicos Infanto-Juvenis Solicitados nas Unidades B&#225;sicas de Sa&#250;de em Campinas/SP, Brasil: Um Estudo Laboratorial Transversal. Arq Bras Cardiol. 2020;114(1):47-56.</mixed-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reuter</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Brand</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>PT</given-names>
            </name>
            <name>
              <surname>Reuter</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Renner</surname>
              <given-names>JDP</given-names>
            </name>
            <name>
              <surname>Franke</surname>
              <given-names>SIR</given-names>
            </name>
            <name>
              <surname>Mello</surname>
              <given-names>ED</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Rela&#231;&#227;o entre Dislipidemia, Fatores Culturais e Aptid&#227;o Cardiorrespirat&#243;ria em Escolares</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2019</year>
          <volume>112</volume>
          <issue>6</issue>
          <fpage>729</fpage>
          <lpage>736</lpage>
        </element-citation>
        <mixed-citation>3. Reuter CP, Brand C, Silva PT, Reuter M, Renner JDP, Franke SIR, Mello ED, et al. Rela&#231;&#227;o entre Dislipidemia, Fatores Culturais e Aptid&#227;o Cardiorrespirat&#243;ria em Escolares. Arq Bras Cardiol. 2019;112(6):729-36.</mixed-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cesena</surname>
              <given-names>FHY</given-names>
            </name>
            <name>
              <surname>Valente</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Santos</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Bittencourt</surname>
              <given-names>MS</given-names>
            </name>
          </person-group>
          <article-title>Risco Cardiovascular e Elegibilidade Para Estatina na Preven&#231;&#227;o Prim&#225;ria: Compara&#231;&#227;o Entre a Diretriz Brasileira e a Diretriz da AHA/ACC</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2020</year>
          <volume>115</volume>
          <issue>3</issue>
          <fpage>440</fpage>
          <lpage>449</lpage>
        </element-citation>
        <mixed-citation>4. Cesena FHY, Valente VA, Santos RD, Bittencourt MS. Risco Cardiovascular e Elegibilidade Para Estatina na Preven&#231;&#227;o Prim&#225;ria: Compara&#231;&#227;o Entre a Diretriz Brasileira e a Diretriz da AHA/ACC. Arq Bras Cardiol. 2020;115(3):440-9.</mixed-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stein</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Raal</surname>
              <given-names>FJ</given-names>
            </name>
          </person-group>
          <article-title>Lipid-Lowering Drug Therapy for CVD Prevention: Looking into the Future</article-title>
          <source>Curr Cardiol Rep</source>
          <year>2015</year>
          <volume>17</volume>
          <issue>11</issue>
          <fpage>104</fpage>
          <lpage>104</lpage>
        </element-citation>
        <mixed-citation>5. Stein EA, Raal FJ. Lipid-Lowering Drug Therapy for CVD Prevention: Looking into the Future. Curr Cardiol Rep. 2015;17(11):104.</mixed-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Furtado</surname>
              <given-names>RHM</given-names>
            </name>
            <name>
              <surname>Genestreti</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Dal&#231;&#243;quio</surname>
              <given-names>TF</given-names>
            </name>
            <name>
              <surname>Baracioli</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Lima</surname>
              <given-names>FG</given-names>
            </name>
            <name>
              <surname>Franci</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Giraldez</surname>
              <given-names>RRCV</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Associa&#231;&#227;o entre Terapia com Estatinas e Menor Incid&#234;ncia de Hiperglicemia em Pacientes Internados com S&#237;ndromes Coronarianas Agudas</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2021</year>
          <volume>116</volume>
          <issue>2</issue>
          <fpage>285</fpage>
          <lpage>294</lpage>
        </element-citation>
        <mixed-citation>6. Furtado RHM, Genestreti PR, Dal&#231;&#243;quio TF, Baracioli LM, Lima FG, Franci A, Giraldez RRCV, et al. Associa&#231;&#227;o entre Terapia com Estatinas e Menor Incid&#234;ncia de Hiperglicemia em Pacientes Internados com S&#237;ndromes Coronarianas Agudas. Arq Bras Cardiol. 2021;116(2):285-94.</mixed-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Costa</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Buttelli</surname>
              <given-names>ACK</given-names>
            </name>
            <name>
              <surname>Coconcelli</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Pereira</surname>
              <given-names>LF</given-names>
            </name>
            <name>
              <surname>Vieira</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Fagundes</surname>
              <given-names>AO</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Water-Based Aerobic and Resistance Training as a Treatment to Improve the Lipid Profile of Women With Dyslipidemia: A Randomized Controlled Trial</article-title>
          <source>J Phys Act Health</source>
          <year>2019</year>
          <volume>16</volume>
          <issue>5</issue>
          <fpage>348</fpage>
          <lpage>354</lpage>
        </element-citation>
        <mixed-citation>7. Costa RR, Buttelli ACK, Coconcelli L, Pereira LF, Vieira AF, Fagundes AO, e al. Water-Based Aerobic and Resistance Training as a Treatment to Improve the Lipid Profile of Women With Dyslipidemia: A Randomized Controlled Trial. J Phys Act Health. 2019;16(5):348-54.</mixed-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brianezi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ornelas</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Gehrke</surname>
              <given-names>FS</given-names>
            </name>
            <name>
              <surname>Fonseca</surname>
              <given-names>FLA</given-names>
            </name>
            <name>
              <surname>Alves</surname>
              <given-names>BCA</given-names>
            </name>
            <name>
              <surname>Sousa</surname>
              <given-names>LVA</given-names>
            </name>
            <name>
              <surname>Souza</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Efeitos do Treinamento F&#237;sico sobre o Mioc&#225;rdio de Camundongos LDLr Knockout Ovariectomizadas: MMP-2 e -9, Col&#225;geno I/III, Inflama&#231;&#227;o e Estresse Oxidativo</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2020</year>
          <volume>114</volume>
          <issue>1</issue>
          <fpage>100</fpage>
          <lpage>105</lpage>
        </element-citation>
        <mixed-citation>8. Brianezi L, Ornelas E, Gehrke FS, Fonseca FLA, Alves BCA, Sousa LVA, Souza J, et al. Efeitos do Treinamento F&#237;sico sobre o Mioc&#225;rdio de Camundongos LDLr Knockout Ovariectomizadas: MMP-2 e -9, Col&#225;geno I/III, Inflama&#231;&#227;o e Estresse Oxidativo. Arq Bras Cardiol. 2020;114(1):100-5.</mixed-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marongiu</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Crisafulli</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Cardioprotection acquired through exercise: the role of ischemic preconditioning</article-title>
          <source>Curr Cardiol Rev</source>
          <year>2014</year>
          <volume>10</volume>
          <issue>4</issue>
          <fpage>336</fpage>
          <lpage>348</lpage>
        </element-citation>
        <mixed-citation>9. Marongiu E, Crisafulli A. Cardioprotection acquired through exercise: the role of ischemic preconditioning. Curr Cardiol Rev. 2014;10(4):336-48.</mixed-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Costa</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Vieira</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Coconcelli</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Fagundes</surname>
              <given-names>AO</given-names>
            </name>
            <name>
              <surname>Buttelli</surname>
              <given-names>ACK</given-names>
            </name>
            <name>
              <surname>Pereira</surname>
              <given-names>LF</given-names>
            </name>
            <name>
              <surname>Stein</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kruel</surname>
              <given-names>LFM</given-names>
            </name>
          </person-group>
          <article-title>Statin Use Improves Cardiometabolic Protection Promoted By Physical Training in an Aquatic Environment: A Randomized Clinical Trial</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2021</year>
          <volume>117</volume>
          <issue>2</issue>
          <fpage>270</fpage>
          <lpage>278</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.36660/abc.20200197">https://doi.org/10.36660/abc.20200197</ext-link>
          </comment>
        </element-citation>
        <mixed-citation>10. Costa RR, Vieira AF, Coconcelli L, Fagundes AO, Buttelli ACK, Pereira LF, Stein R, Kruel LFM. Statin Use Improves Cardiometabolic Protection Promoted By Physical Training in an Aquatic Environment: A Randomized Clinical Trial. Arq Bras Cardiol. 2021; 117(2):270-278. doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.36660/abc.20200197">https://doi.org/10.36660/abc.20200197</ext-link></mixed-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Correa</surname>
              <given-names>CV</given-names>
            </name>
            <name>
              <surname>Teixeira</surname>
              <given-names>BC</given-names>
            </name>
            <name>
              <surname>Bittencourt</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>AR</given-names>
            </name>
          </person-group>
          <article-title>Effects of strength training on blood lipoprotein concentrations in postmenopausal women</article-title>
          <source>J Vasc Bras</source>
          <year>2014</year>
          <volume>13</volume>
          <issue>4</issue>
          <fpage>312</fpage>
          <lpage>317</lpage>
        </element-citation>
        <mixed-citation>11. Correa CV; Teixeira BC; Bittencourt A; Oliveira AR. Effects of strength training on blood lipoprotein concentrations in postmenopausal women. J Vasc Bras. 2014;13(4):312-7.</mixed-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="S01" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Short Editorial</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Statin Associated With Physical Training: A Perfect Combination</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Motta</surname>
            <given-names>Stephanie Bastos da</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="editor">
          <name>
            <surname>Toledes</surname>
            <given-names>Vanessa Caroline</given-names>
          </name>
          <xref ref-type="aff" rid="aff5">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="editor">
          <contrib-id contrib-id-type="orcid">0000-0002-6327-1428</contrib-id>
          <name>
            <surname>Franzoni</surname>
            <given-names>Leandro</given-names>
          </name>
          <xref ref-type="aff" rid="aff6">
            <sup>3</sup>
          </xref>
          <xref ref-type="corresp" rid="c2"/>
        </contrib>
        <aff id="aff4">
          <label>1</label>
          <addr-line>
            <named-content content-type="city">Porto Alegre</named-content>
            <named-content content-type="state">RS</named-content>
          </addr-line>
          <country country="BR">Brazil</country>
          <institution content-type="original">Hospital de Cl&#237;nicas de Porto Alegre - Grupo de Vascular e Exerc&#237;cio &#8211; VascuEx, Porto Alegre, RS - Brazil</institution>
        </aff>
        <aff id="aff5">
          <label>2</label>
          <addr-line>
            <named-content content-type="city">Santo &#194;ngelo</named-content>
            <named-content content-type="state">RS</named-content>
          </addr-line>
          <country country="BR">Brazil</country>
          <institution content-type="original">Faculdade Cenecista Santo &#194;ngelo - Curso de Fisioterapia, Santo &#194;ngelo, RS - Brazil</institution>
        </aff>
        <aff id="aff6">
          <label>3</label>
          <addr-line>
            <named-content content-type="city">Porto Alegre</named-content>
            <named-content content-type="state">RS</named-content>
          </addr-line>
          <country country="BR">Brazil</country>
          <institution content-type="original">Universidade Federal do Rio Grande do Sul - UFRGS, Porto Alegre, RS - Brazilx</institution>
        </aff>
      </contrib-group>
      <author-notes>
        <corresp id="c2"><bold>Mailing Address: Leandro Franzoni</bold> &#8226; Universidade Federal do Rio Grande do Sul &#8211; UFRGS - Rua Itabora&#237;, 683. Postal Code <postal-code>90040-060</postal-code>, Porto Alegre, RS &#8211; Brazil. E-mail: <email>franzoni_77@hotmail.com</email></corresp>
      </author-notes>
      <kwd-group xml:lang="en">
        <title>Keywords:</title>
        <kwd>Dyslipidemias/prevention and control</kwd>
        <kwd>Metabolic Syndrome X</kwd>
        <kwd>Hydroxymethylglutaril-CoA-Reductases</kwd>
        <kwd>Risk Factors</kwd>
        <kwd>Exercise</kwd>
        <kwd>Sports</kwd>
        <kwd>Swimming</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>Dyslipidemia and metabolic syndrome have grown exponentially over the recent years, including in children, mainly due to the low quality of food and the high level of a sedentary lifestyle.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref><sup>&#8211;</sup><xref ref-type="bibr" rid="B3"><sup>3</sup></xref> These two diseases are important risk factors for the development of cardiovascular diseases.<xref ref-type="bibr" rid="B4"><sup>4</sup></xref> Reduction of low-density lipoprotein (LDL), as well as total cholesterol (TC) and the TC to high-density lipoprotein ratio (HDL &#8211; TC/HDL) are the main forms of cardiometabolic prevention.<xref ref-type="bibr" rid="B5"><sup>5</sup></xref> The use of statins is considered a standard treatment and the most effective pharmacological measure to improve the lipid profile.<xref ref-type="bibr" rid="B6"><sup>6</sup></xref> However, there are non-pharmacological alternatives that are also effective, one of which is physical exercise.</p>
      <p>There is evidence on the importance of regular physical training as a form of primary or secondary prevention in the development or worsening of cardiometabolic diseases.<xref ref-type="bibr" rid="B7"><sup>7</sup></xref><sup>&#8211;</sup><xref ref-type="bibr" rid="B9"><sup>9</sup></xref> However, there is no consensus on the effect of combining statins with physical training, two powerful tools that, combined, can promote an even greater impact on the lipid profile. This is what the Costa et al.<xref ref-type="bibr" rid="B10"><sup>10</sup></xref> did in this edition of <italic>Arquivos Brasileiros de Cardiologia</italic> &#8212; they analyzed the influence of simvastatin on lipid adaptations resulting from aerobic and strength water training in elderly women with dyslipidemia. To this end, 69 female elderly sedentary dyslipidemic non-users and users of simvastatin (20 mg and 40 mg) (66.13&#177;5.13 years) were analyzed.</p>
      <p>Below are the main methodological points of the article: it is a randomized clinical trial with 3 groups (aerobic water training &#8211; WA; strength water training &#8211; WR; control group &#8211; CG). The intervention lasted 10 weeks (2 times a week) for all groups. The WA group included 23 women (10 using statin and 13 not using statin); the WR group consisted of 23 women (9 using statin and 14 not using statin); and the CG consisted of 23 women (9 not using statin and 14 not using statin). This is the first positive point of the study: well-executed randomization with equal sample n in all groups and correct distribution of statin use.</p>
      <p>Regarding the water training program, participants of the WA and WR groups attended 2 induction sessions before the beginning of follow-up. Besides, exercise intensity was increased after 5 weeks of intervention. The exercise sessions lasted 45 minutes, including 8 minutes of warm-up, 30 minutes of exercise and 7 minutes of cool-down. For the WA group, interval training was adopted with an intensity of 90% to 100% of the heart rate corresponding to the anaerobic threshold (HR<sub>AT</sub>). The WR group performed the exercises adopting a maximum execution speed, and maintained a fixed duration of 1 minute and 20 seconds for each exercise, while the CG performed a non-periodized program of immersion relaxation exercises in order to maintain the HART same number of weekly sessions as the other groups. The second merit of the study was to control exercise intensity by HR<sub>AT</sub>, in addition to periodizing physical training, planning an increased intensity during follow-up.</p>
      <p>Below are the main findings of the study: in summary, statin use associated with exercise training improves LDL, TC and TC/HDL. How much? Participants medicated for LDL: &#8722;5.58 to 25.18 mg.dl<sup>&#8722;1</sup>; TC: &#8722;3.41 to 25.89 mg.dl<sup>&#8722;1</sup>; TC/HDL: &#8722;0.37 to 0.61 mg.dl<sup>&#8722;1</sup>, with significant p compared to non-medicated participants. This reduction is only statistically significant for the WR group. In general, the use of statins associated with strength water training seems to be the most effective strategy in reducing the lipid parameters evaluated in the study.</p>
      <p>We are aware of the importance of aerobic physical training, especially for its protection against multiple cardiovascular risk factors. However, there is evidence suggesting that strength training is the most effective tool to improve the lipid profile, especially increasing HDL, and consequently reducing TC/HDL.<xref ref-type="bibr" rid="B11"><sup>11</sup></xref> During clinical practice, specialists know that combined physical training, that is, aerobic and strength training together, in the same session or in different sessions, has benefits in several parameters and turns out to be the training style most used in professional daily life, adding up the benefits of aerobic exercise and strength exercise. The study has many merits, but we suggest future studies comparing the effect of combined training and studies on dyslipidemic men, including an expanded age range, as these study findings only apply to elderly women.</p>
    </body>
    <back>
      <fn-group>
        <fn fn-type="other" id="fn2">
          <p>Short Editorial related to the article: Statin Use Improves Cardiometabolic Protection Promoted By Physical Training in an Aquatic Environment: A Randomized Clinical Trial</p>
        </fn>
      </fn-group>
      <ack>
        <title>Acknowledgements</title>
        <p>To <italic>Coordena&#231;&#227;o de Aperfei&#231;oamento de Pessoal de N&#237;vel Superior (CAPES)</italic> for granting the doctoral scholarship and to the Health Sciences Program: Cardiology and Cardiovascular Sciences from Universidade Federal do Rio Grande do Sul for the job opportunity.</p>
      </ack>
    </back>
  </sub-article>
</article>
